BCPC FY2025 SEC EDGAR DEF 14A #30 of 168 in industry

Balchem Corp CEO pay ratio

The CEO earned $7.9M in FY2025 against median worker pay of $58,406 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
MD
Filing date
2026-04-27
Industry
Chemicals & Pharmaceuticals
Industry rank
#30/168

Data updated August 2026

Subscribe to Balchem Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
135:1
Moderate (Scale: 0–1000:1)
CEO pay
$7.9M
Median worker
$58,406

Answer first

Balchem Corp's FY2025 CEO total of $7.9M ranks #694 of 1,423 complete filings; its 135:1 pay ratio ranks #485. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $58,406. Industry placement uses the FY2025 SIC-28 peer cohort (# 30 of 168, 83rd percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#694
$7.9M of 1,423 FY2025
Ratio rank
#485
135:1 of 1,423
Industry pct
83rd
top quartile of industry peers by pay ratio

How Balchem Corp ranks nationally

Balchem Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$7,894,874 Top 49% higher than 51% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). This entry sits in this band. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Balchem Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($7.9M) against pay ratio (135:1) for Balchem Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both05747903.811495807.517243711.322991615.137.0:164.3:191.5:1118.7:1145.9:1CEO total payPay ratio (CEO : median worker)Balchem Corp, CEO total pay: 7894874 · Pay ratio (CEO : median worker): 135:1Balchem CorpAmphastar Pharmaceuticals, Inc., CEO total pay: 8309350 · Pay ratio (CEO : median worker): 135:1Amphastar Pharmaceuticals, Inc.Fuller H B Co, CEO total pay: 8830569 · Pay ratio (CEO : median worker): 137:1Fuller H B CoBristol Myers Squibb Co, CEO total pay: 21902021 · Pay ratio (CEO : median worker): 131:1Bristol Myers Squibb CoAxalta Coating Systems Ltd., CEO total pay: 9551721 · Pay ratio (CEO : median worker): 130:1Axalta Coating Systems Ltd.LyondellBasell Industries N.V., CEO total pay: 110140 · Pay ratio (CEO : median worker): 141:1LyondellBasell Industries N.V.
Balchem Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Balchem Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Balchem Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
135:1
FY2025
vs prior FY
+15:1
from FY2024 120:1
CEO $ YoY
+15%
$7.9M latest
Filings shown
5
FY2021–2025
Balchem Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $5.8M - $59,524 97:1 -
2022 $11.9M +107% $60,435 198:1 +101:1
2023 $5.9M -51% $63,793 92:1 -106:1
2024 $6.9M +17% $57,332 120:1 +28:1
2025 $7.9M +15% $58,406 135:1 +15:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 9326, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
135:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$7.9M
Companies in Industry
168
vs. Industry Median
Above
#30 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Balchem Corp: MID · HEAVY pay ratio

Balchem Corp's FY2025 ratio 135:1 ranks #30 of 168 Chemicals & Pharmaceuticals filers (83rd percentile). the CEO earned 135× the median employee ($58,406) in FY2025.

Median employee $58,406 (PAR-MED); MID · HEAVY stamps put about 135 median-wage years per CEO year.

CEO Total Pay

$7.9M

FY2025 Summary Compensation, near median

Pay Ratio

135:1

Near industry median

Balchem Corp in the higher Chemicals & Pharmaceuticals third

Balchem Corp's FY2025 ratio 135:1 ranks #30 of 168 Chemicals & Pharmaceuticals filers (83rd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Balchem Corp's $7.9M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #694 and ratio rank #485 split - treat 135:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$7.9M
Median Employee Pay
$58,406
Pay Ratio
135:1
Filing Date
2026-04-27

Company Info

Ticker
BCPC
CIK
9326
Industry
Chemicals & Pharmaceuticals
SIC Code
2800
State
MD
View SEC filings →
SEC EDGAR DEF 14A for CIK 9326, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Balchem Corp's FY2025 ratio 135:1 ranks #30 of 168 Chemicals & Pharmaceuticals filers (83rd percentile).

Read with Balchem Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · PAR-MED.

Harmony Biosciences Holdings, Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.9M (Δ $5K heavier vs Balchem Corp); MODEST · ELITE-MED vs this page's MID · HEAVY · PAR-MED.
CarGurus, Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.9M (Δ $6K lighter vs Balchem Corp); MODEST · ELITE-MED vs this page's MID · HEAVY · PAR-MED.
QXO Insulation, LLC · HEAVY

ABS(ceo_total_comp) peer at $7.9M (Δ $7K lighter vs Balchem Corp); MID · PAR-MED vs this page's MID · HEAVY · PAR-MED.
Interface Inc · HEAVY

ABS(ceo_total_comp) peer at $7.9M (Δ $12K heavier vs Balchem Corp); MID · PAR-MED vs this page's MID · HEAVY · PAR-MED.
Amphastar Pharmaceuticals, Inc. (SIC 28 pole)

Amphastar Pharmaceuticals, Inc. stamps MID · HEAVY nearest in-SIC by ABS(pay_ratio) to Balchem Corp's MID filing.
National dual ranks · #694/#485

Balchem Corp's FY2025 package sits #694 by CEO dollars and #485 by ratio under HEAVY · MID.
Comp structure · HEAVY

Balchem Corp's HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Balchem Corp (CIK 9326), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.